RecruitingPhase 4NCT07459049

"Effect of Ibuprofen on Acute Inflammatory Response After One-Stage Periodontal Therapy"

Efficacy Of Ibuprofen In Reducing Acute Inflammatory Response Following One Stage Non- Surgical Periodontal Therapy (A Randomized Clinical Trial )


Sponsor

University of Baghdad

Enrollment

30 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this ( Clinical Trial ) is to evaluate the efficacy of Ibuprofen in reducing acute inflammatory response (hs-CRP, ProCT, IL-6) after one hour and one week following one stage non surgical periodontal therapy. The main question it aims to answer is: "Does Ibuprofen effectively reduce the acute inflammatory response ( hs-CRP, ProCT, IL-6) following one-stage non-surgical periodontal therapy?"


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This Phase 4 clinical trial examines whether taking ibuprofen (400 mg, three times a day for 3 days) around the time of a full-mouth deep cleaning procedure (root surface debridement) can reduce the acute inflammatory response — measured by blood markers including hs-CRP, procalcitonin, and interleukin-6 — that commonly follows this dental treatment for periodontitis (gum disease). The study compares adults who receive ibuprofen before and after the procedure to those who undergo the procedure without ibuprofen. Systemically healthy adults over 18 with generalized unstable periodontitis and pocket depths of at least 4 mm, who have no allergy to NSAIDs, no peptic ulcer disease, and no recent periodontal treatment in the last 3 months, may be eligible. Participation involves a baseline dental assessment, the cleaning procedure, and a follow-up visit at 1 week with blood tests and questionnaires. This summary was generated by AI to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURENon surgical root surface debridement in one stage without receiving Ibuprofen

Control group: After one week from baseline visit which include supragingival debridement by using ultrasonic device . sites will receive root surface debridement (RSD) using area specific (Gracey) curettes (Medesy, Italy). Without receiving Ibuprofen.

DRUGNon surgical root surface debridement in one stage with receiving Ibuprofen

Test group: After one week from baseline visit which include supragingival debridement by using ultrasonic device . Test group will receive first dose of Ibuprofen (400 mg) administer one hour before root surface debridement and the subsequent doses will be taken 3 times daily for a duration of 3 days after RSD.


Locations(1)

College of Dentistry, University of Baghdad

Baghdad, Iraq

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07459049


Related Trials